Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP774226.RAsZOn15TECNLRLYybIHO-ls3YMwfNRqJG2Vatod1A4Dg130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774226.RAsZOn15TECNLRLYybIHO-ls3YMwfNRqJG2Vatod1A4Dg130_provenance.
• NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.
• NP789110.RAD6-aUOfYdOfatLOSamoF7aSTg0jTwzOnmbEKUr2SGTs130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789110.RAD6-aUOfYdOfatLOSamoF7aSTg0jTwzOnmbEKUr2SGTs130_provenance.
• NP415727.RAwJwPinkGgpavve5qxThZXSDhvsOHCPO4M63JfJ-rGn4130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415727.RAwJwPinkGgpavve5qxThZXSDhvsOHCPO4M63JfJ-rGn4130_provenance.
• NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.
• NP607035.RAHSaXhsi2aut5GR4WFDh0EONdiCHOq4ttEBdxBDeeHN8130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607035.RAHSaXhsi2aut5GR4WFDh0EONdiCHOq4ttEBdxBDeeHN8130_provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP978507.RAAJns1UCTVaf3HDMUVednIImMoiWgebBv3LjCX3RzuqM130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978507.RAAJns1UCTVaf3HDMUVednIImMoiWgebBv3LjCX3RzuqM130_provenance.
• NP805923.RAHVsidi8l4QoXYxAWcnTMDIeJHM7R-PHH_ACtgEjkICg130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805923.RAHVsidi8l4QoXYxAWcnTMDIeJHM7R-PHH_ACtgEjkICg130_provenance.
• NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555287.RArY_Z8CAZrK4c6tKK_M4oe1dFH62plMK0uo8nlXbC3Sc130_provenance.
• assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605966.RAhZ0C9AN17woK62z4mAATMoMjaGks3jKX6XQi3g6xWcE130_provenance.
• NP418694.RAqw_oINF-hAvlb0bsgbDvMWLeMWC-UQfmnBua99tlbKc130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418694.RAqw_oINF-hAvlb0bsgbDvMWLeMWC-UQfmnBua99tlbKc130_provenance.
• NP913997.RAIBVUATdiM6iHtK58J5gBbJljnIB7F_aI4Zh91XMbGj4130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913997.RAIBVUATdiM6iHtK58J5gBbJljnIB7F_aI4Zh91XMbGj4130_provenance.
• NP781411.RA-2Fdd5-tO1ZkolO86yyu07OmUCRQbtNtV6JWJWh_mmw130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781411.RA-2Fdd5-tO1ZkolO86yyu07OmUCRQbtNtV6JWJWh_mmw130_provenance.
• NP418695.RALrC3UN1kX21bfI7sjyk7YladdYubOKGFbfPv3ej_fhc130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418695.RALrC3UN1kX21bfI7sjyk7YladdYubOKGFbfPv3ej_fhc130_provenance.
• NP418692.RA8HjHPKixywiL62evNJOFt8HeAUDSYs-9eRVMi01FMkY130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418692.RA8HjHPKixywiL62evNJOFt8HeAUDSYs-9eRVMi01FMkY130_provenance.
• NP418693.RA9d4O01fXJTcgYVVndRJcOA9nsWBHCMEU5tJHwY0bQCk130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418693.RA9d4O01fXJTcgYVVndRJcOA9nsWBHCMEU5tJHwY0bQCk130_provenance.
• NP418696.RA-ol-qr9Uxup269CDpaud9nKWZPr7FcLYeOAgxbS0TVg130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418696.RA-ol-qr9Uxup269CDpaud9nKWZPr7FcLYeOAgxbS0TVg130_provenance.
• NP418698.RA3GWfaD_jA5B3i5eqIm0sZIVARO5cCE1iXTYkG5P-gus130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418698.RA3GWfaD_jA5B3i5eqIm0sZIVARO5cCE1iXTYkG5P-gus130_provenance.